Edarbi Interactions
There are 280 drugs known to interact with Edarbi (azilsartan medoxomil), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 32 are major, 246 are moderate, and 2 are minor.
- View all 280 medications that may interact with Edarbi
- View Edarbi alcohol/food interactions (1)
- View Edarbi disease interactions (8)
Most frequently checked interactions
View interaction reports for Edarbi (azilsartan medoxomil) and the medicines listed below.
- allopurinol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- Bystolic (nebivolol)
- carvedilol
- clonidine
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- Eliquis (apixaban)
- furosemide
- gabapentin
- hydralazine
- hydrochlorothiazide
- Jardiance (empagliflozin)
- levothyroxine
- losartan
- melatonin
- metformin
- metoprolol
- montelukast
- omeprazole
- pantoprazole
- rosuvastatin
- Synthroid (levothyroxine)
- tamsulosin
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Edarbi alcohol/food interactions
There is 1 alcohol/food interaction with Edarbi (azilsartan medoxomil).
Edarbi disease interactions
There are 8 disease interactions with Edarbi (azilsartan medoxomil) which include:
Report options
QR code containing a link to this page
More about Edarbi (azilsartan medoxomil)
- Edarbi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (45)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: angiotensin receptor blockers
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
